Skip to main content
Erschienen in: European Radiology 2/2009

01.02.2009 | Urogenital

Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings

verfasst von: Laurent Lemaitre, Philippe Puech, Edouard Poncelet, Sébastien Bouyé, Xavier Leroy, Jacques Biserte, Arnauld Villers

Erschienen in: European Radiology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

The purpose of the study was to relate morphometric features of prostate cancers in the anterior compartment of the prostate by dynamic contrast-enhanced (DCE) MRI to subsequent histopathologic findings. We prospectively performed DCE-MRI before biopsy in patients with suspected prostate cancer and selected those showing both a suspicious lesion at MRI and positive biopsies in the anterior compartment of the gland. Tumor contours, margins, largest surface areas and volumes were assessed at MRI and histopathology, when available. Anterior compartment tumors were classified according to transition zone (TZ) boundaries with the peripheral zone (PZ) or with the anterior fibromuscular stroma (SFMA). Forty-three patients were included in this study [median PSA 12.7 ng/ml (3.6–72)]. Whole-mount radical prostatectomy specimens were available in 27 cases. Of the anterior cancers, 89% had ill-defined margins at T2-weighted MRI. Cancer location and contour established at MRI agreed well with histopathology in the 27 cases. Median largest surface area and volume were 1.38 cm² (0.35–5.82) and 1.01 cc (0.15–7.4) for MRI versus 1.86 cm² (0.2–14) and 2.84 cc (0.33–28.92) for histopathology with respective correlation coefficients (r²) of 0.73 and 0.69. The site of origin could be accurately determined for the 15 tumors of less than 3 cc. We found a good relationship between DCE-MRI and histopathology for localization, morphologic description and volume assessment of anterior prostate cancers.
Literatur
1.
Zurück zum Zitat Namimoto T, Morishita S, Saitoh R, Kudoh J, Yamashita Y, Takahashi M (1998) The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate. Comput Med Imaging Graph 22(3):239–245PubMedCrossRef Namimoto T, Morishita S, Saitoh R, Kudoh J, Yamashita Y, Takahashi M (1998) The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate. Comput Med Imaging Graph 22(3):239–245PubMedCrossRef
2.
Zurück zum Zitat Cruz M, Tsuda K, Narumi Y, Kuroiwa Y, Nose T, Kojima Y et al (2002) Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 12(2):357–365PubMedCrossRef Cruz M, Tsuda K, Narumi Y, Kuroiwa Y, Nose T, Kojima Y et al (2002) Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 12(2):357–365PubMedCrossRef
3.
Zurück zum Zitat Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M et al (2003) Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging-initial results. Radiology 229(1):241–247PubMedCrossRef Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M et al (2003) Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging-initial results. Radiology 229(1):241–247PubMedCrossRef
4.
Zurück zum Zitat van Dorsten FA, van der Graaf M, Engelbrecht MR, van Leenders GJ, Verhofstad A, Rijpkema M et al (2004) Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20(2):279–287PubMedCrossRef van Dorsten FA, van der Graaf M, Engelbrecht MR, van Leenders GJ, Verhofstad A, Rijpkema M et al (2004) Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20(2):279–287PubMedCrossRef
5.
Zurück zum Zitat Futterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241(2):449–458PubMedCrossRef Futterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241(2):449–458PubMedCrossRef
6.
Zurück zum Zitat Sato C, Naganawa S, Nakamura T, Kumada H, Miura S, Takizawa O et al (2005) Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21(3):258–262PubMedCrossRef Sato C, Naganawa S, Nakamura T, Kumada H, Miura S, Takizawa O et al (2005) Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21(3):258–262PubMedCrossRef
7.
Zurück zum Zitat Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176(6 Pt 1):2432–2437PubMedCrossRef Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176(6 Pt 1):2432–2437PubMedCrossRef
8.
Zurück zum Zitat McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897–906PubMedCrossRef McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897–906PubMedCrossRef
9.
Zurück zum Zitat Turnbull LW, Buckley DL, Turnbull LS, Liney GP, Knowles AJ (1999) Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 9(2):311–316PubMedCrossRef Turnbull LW, Buckley DL, Turnbull LS, Liney GP, Knowles AJ (1999) Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 9(2):311–316PubMedCrossRef
10.
Zurück zum Zitat Muramoto S, Uematsu H, Kimura H, Ishimori Y, Sadato N, Oyama N et al (2002) Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging. Eur J Radiol 44(1):52–58PubMedCrossRef Muramoto S, Uematsu H, Kimura H, Ishimori Y, Sadato N, Oyama N et al (2002) Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging. Eur J Radiol 44(1):52–58PubMedCrossRef
11.
Zurück zum Zitat Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA et al (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 229(1):248–254PubMedCrossRef Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA et al (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 229(1):248–254PubMedCrossRef
12.
Zurück zum Zitat Li H, Sugimura K, Kaji Y, Kitamura Y, Fujii M, Hara I et al (2006) Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol 186(3):729–742PubMedCrossRef Li H, Sugimura K, Kaji Y, Kitamura Y, Fujii M, Hara I et al (2006) Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol 186(3):729–742PubMedCrossRef
13.
Zurück zum Zitat Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D et al (2006) Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology. 239(3):784–792PubMedCrossRef Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D et al (2006) Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology. 239(3):784–792PubMedCrossRef
14.
Zurück zum Zitat Puech P, Betrouni N, Viard R, Villers A, Leroy X, Lemaitre L.(2007) Prostate cancer computer-assisted diagnosis software using dynamic contrast-enhanced MRI. Engineering in Medicine and Biology Society, EMBS 2007 29th Annual International Conference of the IEEE; 2007; p. 5567–5570. Puech P, Betrouni N, Viard R, Villers A, Leroy X, Lemaitre L.(2007) Prostate cancer computer-assisted diagnosis software using dynamic contrast-enhanced MRI. Engineering in Medicine and Biology Society, EMBS 2007 29th Annual International Conference of the IEEE; 2007; p. 5567–5570.
15.
Zurück zum Zitat Preziosi P, Orlacchio A, Di Giambattista G, Di Renzi P, Bortolotti L, Fabiano A et al (2003) Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol. 13(5):925–930PubMed Preziosi P, Orlacchio A, Di Giambattista G, Di Renzi P, Bortolotti L, Fabiano A et al (2003) Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol. 13(5):925–930PubMed
16.
Zurück zum Zitat Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sozen S, Gill H (1998) Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 160(6 Pt 2):2412–2417PubMed Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sozen S, Gill H (1998) Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 160(6 Pt 2):2412–2417PubMed
17.
Zurück zum Zitat Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM (2000) Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 163(4):1155–1160PubMedCrossRef Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM (2000) Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 163(4):1155–1160PubMedCrossRef
18.
Zurück zum Zitat Stamey TA, McNeal JE, Freiha FS, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139(6):1235–1241PubMed Stamey TA, McNeal JE, Freiha FS, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139(6):1235–1241PubMed
19.
Zurück zum Zitat Augustin H, Erbersdobler A, Graefen M, Jaekel T, Haese A, Huland H et al (2003) Differences in biopsy features between prostate cancers located in the transition and peripheral zone. BJU Int 91(6):477–481PubMedCrossRef Augustin H, Erbersdobler A, Graefen M, Jaekel T, Haese A, Huland H et al (2003) Differences in biopsy features between prostate cancers located in the transition and peripheral zone. BJU Int 91(6):477–481PubMedCrossRef
20.
Zurück zum Zitat McNeal JE, Haillot O (2001) Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. Prostate 49(1):48–57PubMedCrossRef McNeal JE, Haillot O (2001) Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. Prostate 49(1):48–57PubMedCrossRef
21.
Zurück zum Zitat Futterer JJ, Engelbrecht MR, Jager GJ, Hartman RP, King BF, Hulsbergen-Van de Kaa CA et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils: Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17(4):1055–1065 Epub 2006 Oct 6PubMedCrossRef Futterer JJ, Engelbrecht MR, Jager GJ, Hartman RP, King BF, Hulsbergen-Van de Kaa CA et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils: Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17(4):1055–1065 Epub 2006 Oct 6PubMedCrossRef
22.
Zurück zum Zitat Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189(2):323–328PubMedCrossRef Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189(2):323–328PubMedCrossRef
23.
Zurück zum Zitat Husband JE, Padhani AR, MacVicar AD, Revell P (1998) Magnetic resonance imaging of prostate cancer: comparison of image quality using endorectal and pelvic phased array coils. Clin Radiol 53(9):673–681PubMedCrossRef Husband JE, Padhani AR, MacVicar AD, Revell P (1998) Magnetic resonance imaging of prostate cancer: comparison of image quality using endorectal and pelvic phased array coils. Clin Radiol 53(9):673–681PubMedCrossRef
24.
Zurück zum Zitat Sosna J, Pedrosa I, Dewolf WC, Mahallati H, Lenkinski RE, Rofsky NM (2004) MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol 11(8):857–862PubMedCrossRef Sosna J, Pedrosa I, Dewolf WC, Mahallati H, Lenkinski RE, Rofsky NM (2004) MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol 11(8):857–862PubMedCrossRef
25.
Zurück zum Zitat Heijmink SW, Futterer JJ, Hambrock T, Takahashi S, Scheenen TW, Huisman HJ et al (2007) Prostate cancer: Body-array versus endorectal coil MR imaging at 3 T — Comparison of image quality, localization, and staging performance. Radiology 244(1):184–195 Epub 2007 May 10PubMedCrossRef Heijmink SW, Futterer JJ, Hambrock T, Takahashi S, Scheenen TW, Huisman HJ et al (2007) Prostate cancer: Body-array versus endorectal coil MR imaging at 3 T — Comparison of image quality, localization, and staging performance. Radiology 244(1):184–195 Epub 2007 May 10PubMedCrossRef
26.
Zurück zum Zitat Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C (2008) MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 246(3):833–844 Epub 2008 Jan 25PubMedCrossRef Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C (2008) MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 246(3):833–844 Epub 2008 Jan 25PubMedCrossRef
27.
Zurück zum Zitat Villers A, Puech P, Leroy X, Biserte J, Fantoni JC, Lemaitre L (2007) Dynamic contrast-enhanced MRI for preoperative identification of localised prostate cancer. Eur Urol [Suppl] 6:525–532CrossRef Villers A, Puech P, Leroy X, Biserte J, Fantoni JC, Lemaitre L (2007) Dynamic contrast-enhanced MRI for preoperative identification of localised prostate cancer. Eur Urol [Suppl] 6:525–532CrossRef
28.
Zurück zum Zitat Tiguert R, Kabbani W, Sakr W, Gheiler EL, Pontes JE (1999) Origin and racial distribution of glandular tissue in the anterior compartment of the prostate: an autopsy study. Prostate 39(4):310–315PubMedCrossRef Tiguert R, Kabbani W, Sakr W, Gheiler EL, Pontes JE (1999) Origin and racial distribution of glandular tissue in the anterior compartment of the prostate: an autopsy study. Prostate 39(4):310–315PubMedCrossRef
30.
Zurück zum Zitat Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 141(5):1091–1094 discussion 3–4PubMed Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 141(5):1091–1094 discussion 3–4PubMed
31.
Zurück zum Zitat Kirkham AP, Emberton M, Allen C (2006) How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50(6):1163–1175PubMedCrossRef Kirkham AP, Emberton M, Allen C (2006) How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50(6):1163–1175PubMedCrossRef
32.
Zurück zum Zitat Quint LE, Van Erp JS, Bland PH, Mandell SH, Del Buono EA, Grossman HB et al (1991) Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. AJR Am J Roentgenol 156(3):511–516PubMed Quint LE, Van Erp JS, Bland PH, Mandell SH, Del Buono EA, Grossman HB et al (1991) Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. AJR Am J Roentgenol 156(3):511–516PubMed
33.
Zurück zum Zitat Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K et al (2004) Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 64(1):101–105PubMedCrossRef Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K et al (2004) Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 64(1):101–105PubMedCrossRef
Metadaten
Titel
Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings
verfasst von
Laurent Lemaitre
Philippe Puech
Edouard Poncelet
Sébastien Bouyé
Xavier Leroy
Jacques Biserte
Arnauld Villers
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 2/2009
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-008-1153-0

Weitere Artikel der Ausgabe 2/2009

European Radiology 2/2009 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.